Tensile Strength of Novel Experimental Hydrophilic Vinyl Polysiloxane Impression MaterialsCompared to Control and Commercial VPS Impression Materials
Journal Title: Journal of Islamabad Medical and Dental College - Year 2018, Vol 7, Issue 1
Abstract
Objective:To measure the tensile strength of novel experimental hydrophilic (medium bodied) vinyl polysiloxane impression materials developed from ab initio in comparison to control and commercial vinyl polysiloxane impression materials.Materialsand Methods:This experimental study was conducted atthe Department of Oral Growth and Development, Bart’s and The London School of Medicine and Dentistry, Queen Mary, University of London, UK from 1stOct 2010 to 28thFebruary 2014. Five novel experimental (medium bodied) VPS impression materials (Exp-I, II, III, IV and V) were developed and evaluated for their effect as crosslinking agent and surfactant on the tensile strength and percent elongation-at-break in comparison to control and three commonly used commercial (medium bodied) VPS impression materials (Aquasil Ultra Monophase, EliteHD Monophase, Extrude. These properties were evaluated using Tenius Olsen (mechanical testing machine).Results:Aquasil Ultra Monophase (Aq M) had a significantly higher Ultimate Tensile Strength (UTS) compared to all commercial and Experimental VPS. Although Exp-III showed the lowest UTS among all the materials but this was only significant for Aq M. On comparing Exp-I (control) with Exp-II, after adding TFDMSOS into Exp-II there was a slight, but not significant, increase in UTS. After adding the surfactant to hydrophilic Exp-III, IV and V, the UTS decreased slightly, but not significantly, compared to Exp-II. After addition of cross-linking agent (TFDMSOS) there was a significant increase in elongation-at-break of Exp-II compared to the control (Exp-I),which was further significantly increased after incorporating the surfactant (Rhodasurf CET-2) in the Exp hydrophilic VPS formulations (Exp-III, IV and V). Elongation-at-break was significantly increased after incorporating the surfactant (Rhodasurf CET-2) in the Exp hydrophilic VPS formulations (Exp-III, IV and V) compared to Exp-II.Conclusion: All Exp VPS had significantly higher % elongation-at-break (more than double) than commercial VPS. Percentage elongation-at-break further increased significantly after adding Rhodasurf CET-2 (Surfactant)
Authors and Affiliations
Sadaf Humayoun
Keywords
Related Articles
- EP ID EP598501
- DOI -
- Views 155
- Downloads 0
C - Reactive Protein as A Predictor of Sepsis in Children Up to 5 Years of Age
Objective: To determine frequency of raised CRP levels in children clinically diagnosed to have sepsis. Patients and Methods: In this cross-sectional study, a total of 91 children up to 5-year age, clinically diagnosed a...
Clinico-Biochemical Profile in Neonates with Birth Asphyxia
Objective: To study the biochemical derangements in neonates with asphyxia having different clinical presentation. Patients and Methods: This cross-sectional study was conducted at Neonatal Intensive Care Unit, Federal G...
Frequency of Helicobacter Pylori Infection in Immune Thrombocytopenia
Objective: To accomplish the comparative analysis of clinical features and laboratory findings in Helicobacter Pylori positive and negative patients with Immune thrombocytopenia. Patients and Methods: This cross sectiona...
Comparison of Anti-Diabetic Activity of Berberis lycium Royle Stem bark (Barberry) and Pioglitazone in Type 2 Diabetes Induced Mice Model
Objective: To compare the anti-diabetic activity of aqueous extract of stem bark of Berberis lycium Royle and Pioglitazone –a thiazolidinedione in a type 2 diabetes mellitus induced male mice model. Material and Methods:...
omparison of Peritonsillar Injection of Lignocaine-Adrenaline and Normal Saline (placebo) Before Tonsillectomy in Terms of Mean Per-Operative Blood Loss
Objective:To compare peritonsillar injection of lignocaine-adrenaline and normal saline (placebo) before tonsillectomy in terms of mean peroperative blood loss.Patientsand Methods:This randomized controlled trial was car...